deltatrials
Completed PHASE1 NCT00003038

Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors

A Phase I Trial of Suramin With Sequential Doxorubicin in Patients With Advanced Solid Tumors

Sponsor: Mayo Clinic

Conditions Adrenocortical Carcinoma Breast Cancer Colorectal Cancer Prostate Cancer Unspecified Adult Solid Tumor, Protocol Specific
Interventions doxorubicin hydrochloride suramin
Updated 5 times since 2017 Last updated: Aug 2, 2011 Started: Oct 31, 1997 Primary completion: Jan 31, 2003 Completion: Jan 31, 2003

Listed as NCT00003038, this PHASE1 trial focuses on Adrenocortical Carcinoma and Breast Cancer and remains completed. Sponsored by Mayo Clinic, it has been updated 5 times since 1997, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1

    First recorded

Oct 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Mayo Clinic
  • National Cancer Institute (NCI)
Data source: Mayo Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Rochester, United States